Clinicopathological features and survival in young taiwanese women with endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 24, Issue 6, 2014, Pages 1015-1020

  Lau, Hei Yu ^a,b   Chen, Yi Jen ^a,b   Yen, Ming Shyen ^a,b   Chao, Kuan Chong ^a,b   Chen, Ru Fen ^a,b   Yeh, Shu O ^a,b   Twu, Nae Fang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Endometrial cancer; Synchronous ovarian cancer; Young women

Indexed keywords

ADULT; ARTICLE; BODY MASS; CANCER GRADING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TAIWAN; AGED; CANCER STAGING; ENDOMETRIAL NEOPLASMS; FOLLOW UP; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN;

EID: 84904181477     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000193     Document Type: Article

References (25)

1. Jemai A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: a clinicopathologic analysis. Am J Obstet Gynecol. 2005;193:1640-1644. (Pubitemid 41540459)
3. The Taiwan Cancer Registry, by the National Department of Health, Cancer Registry Annual Report. 2010.
4. Yamazawa K, Seki K, Matsui H, et al. Prognostic factors in young women with endometrial carcinoma: a report of 20 cases and review of literature. Int J Gynecol Cancer. 2000;10:212-222. (Pubitemid 30626974)
5. Ali-Fehmi R, Cote ML, Arabi MH, et al. Endometrial carcinoma (EC) in women 35 years of age or younger ASCO Meeting Astract. J Clin Oncol. 2007;25:16000.
6. Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575-580. (Pubitemid 40271225)
7. Dubeau L. Etiology and detection of gynecologic cancers. In: CP Morrow JC, DE Townsend, eds. Synopsis of Gynecologic Oncology. 4th ed. New York, NY: Churchill Livingstone; 1993:1-22.
8. Noda K, Yanagawa H, Kurihara S, et al. High risk factors for cancer of the endometrium among Japanese Women. Asia Oceania J Obstet Gynaecol. 1987;13:369-377.
9. Kanazaawa M, Yoshiike N, Osaka T, et al. Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac Clin Nutr. 2002;11:S732-S737.
10. Scully RE, Young RH, Clement PB. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Atlas of Tumor Pathology. Bethesda, MD: Armed Forces Institute of Pathology; 1998.
11. Pan WH, Flegal KM, Chang HY, et al. Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asian. Am J Clin Nutr. 2004;79:31-39. (Pubitemid 41132059)
12. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76-79. (Pubitemid 36026281)
13. Abelson P, Kennedy D. The obesity epidemic. Science. 2004;304:1413. (Pubitemid 38720893)
14. Silventoinen K, Sans S, Tolonen H, et al. Trend in obesity and energy supply in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004;28:710-718. (Pubitemid 38580981)
15. Flegal KM, Carroll MD, Ogden C, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
16. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;8:626-635.
17. Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet. 2002;360:235.
18. Anuurad E, Shiwaku K, Nogi A, et al. The new BMI criteria for Asians by the regional office for the Western Pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health. 2003;45:335-343. (Pubitemid 38036188)
19. Gitsch G, Hanzal E, Jensen D, et al. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol. 1995;85:504Y508.
20. Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case-control study. Am J Obstet Gynecol. 2000;182:23-29. (Pubitemid 30074365)
21. Rieck GC, Freites ON, Williams S. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer. J Obstet Gynaecol. 2005;25:39-41. (Pubitemid 41685674)
22. Lewis-Wambi JS, Jordan VC. Treatment of postmenopausal breast cancer with selective estrogen receptor modulators (SERMs). Breast Dis. 2005;24:93-105.
23. Uharcek P, Mlyneck M, Ravinger J, et al. Prognostic factors in women 45 years of age or younger with endometrial cancer. Int J Gynecol Cancer. 2008;18:324-328. (Pubitemid 351365229)
24. Tran BN, Connell PP, Waggoner S, et al. Characteristics and outcome of endometrial carcinoma patients age 45 years and younger. Am J Clin Oncol. 2000;23:476-480.
25. Navarria I, Usel M, Rapiti E, et al. Young patients with endometrial cancer: how many could be eligible for fertility sparing treatment? Gynecol Oncol. 2009;114:448-451.